Skip to main content
SpringerLink
Log in

Should recommendations for colorectal-cancer screening be changed?

  • Practice Point
  • Published:

From Nature Clinical Practice Oncology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Chlebowski RT et al. (2004) Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med 350: 991–1004

    Article  CAS  Google Scholar 

  2. Imperiale TF et al. (2003) Using risk for advanced proximal colonic neoplasia to tailor endoscopic screening for colorectal cancer. Ann Intern Med 139: 959–965

    Article  Google Scholar 

  3. Macafee DA and Scholefield JH (2003) Population based endoscopic screening for colorectal cancer. Gut 52: 323–326

    Article  CAS  Google Scholar 

  4. Allison JE (2005) Colon Cancer Screening Guidelines 2005: the fecal occult blood test option has become a better FIT Editorial Gastroenterology 129: 745–748

    Article  Google Scholar 

  5. American Cancer Society (2007) Cancer facts and figures 2007. [http://www.cancer.org/downloads/STT/CAFF2007PWSecured.pdf] (accessed 20 April 2007)

Download references

Acknowledgements

The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Division of Gastroenterology, San Francisco General Hospital, 1001 Potrero Avenue NH–3D, San Francisco, CA 94110, USA jallison@medsfgh.ucsf.edu

Authors and Affiliations

  1. JE Allison is a Faculty Member in the Gastroenterology Division, and Clinical Professor of Medicine Emeritus, of the University of California San Francisco, San Francisco, CA, USA.,

    James E Allison

Authors
  1. James E Allison
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

JE Allison serves as a consultant to Quest Diagnostics and Beckman Coulter Diagnostics. To date Dr Allison has received no compensation from either company. Both companies manufacture fecal immunochemical tests for colorectal-cancer screening.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Allison, J. Should recommendations for colorectal-cancer screening be changed?. Nat Rev Clin Oncol 4, 392–393 (2007). https://doi.org/10.1038/ncponc0843

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc0843

  • Springer Nature Limited

Search

Navigation